Canaan X L.P., 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 79,036 shares at $20.61 ($1.6M) on 2018-03-21, disclosed to the SEC on 2018-03-22.
Open-market sale of $1.6M PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.61 | 17,060 | $352K | 21.6% |
| 2 | $20.61 | 17,060 | $352K | 21.6% |
| 3 | $20.61 | 17,699 | $365K | 22.4% |
| 4 | $20.61 | 17,699 | $365K | 22.4% |
| 5 | $20.62 | 4,759 | $98K | 6.0% |
| 6 | $20.62 | 4,759 |
| $98K |
| 6.0% |
| Total | $20.61 avg | 79,036 | $1.6M | 100% |
| Filing → |
| PTGX | BUY | 2016-08-16 | $7.0M | — | Filing → |